(Reuters) — Abbott Laboratories reported solid fourth-quarter earnings and forecast 2010 profit above Wall Street expectations, but weak U.S. sales...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott's Humira raises concerns despite strong quarterly results
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account